Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Hypercoagulability in Patients with Hip Fractures as Determined by Thrombelastography

FY 2017-18

Summary
BackgroundHip fractures account for over 60% of orthopedic hospital admissions. Immobility, surgery, and advanced age increase the risk of blood clot formation. Despite the use of preventative measures, the prevalence of fatal blood clots in the hip fracture population remains high. As such, it is essential to identify those hip fracture patients for whom the benefits of using blood thinners outweigh the potential risks. Thrombelastography (TEG) is a blood test that quantifies a patient's ability to make and dissolve clots and may be used as a novel tool in identifying patients with excessive clotting. TEG measurements provide a wealth of real-time data yet to be fully utilized, especially in the assessment of increased clotting risk.Research QuestionCan TEG analysis be used to identify patients with hip fractures at increased risk for blood clots?Hypotheses: 1) Patients with hip fractures will have increased clotting based on elevated TEG values compared with normal reference values. 2) Some patients will have persistently elevated TEG values 6-weeks after injury.MethodsThe proposed study is a single-centre prospective cohort of hip fracture patients requiring surgical treatment. Patients will undergo serial TEG measurements every 24-hours from hospital arrival until 5-days after surgery. Additionally, follow-up TEG measurements will take place at 2-weeks, 6-weeks and 3-months.Expected OutcomesIt is anticipated that patients with hip fractures will be hypercoagulable and at increased risk of developing blood clots as determined by TEG. As health care becomes increasingly patient-centered, our goal is to use TEG as a point-of-care tool to risk-stratify and provide patient-directed blood clot prevention.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
386562
Name
You Daniel
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Hypercoagulability in Patients with Hip Fractures as Determined by Thrombelastography
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Arthroplasty; Deep Vein Thrombosis; Fracture Fixation; Hip Fracture; Hypercoagulation; Proximal Femur Fracture; Pulmonary Embolism; Thrombelastography; Venous Thromboembolism; Venous Thromboembolism Prophylaxis
Abstract
BackgroundHip fractures account for over 60% of orthopedic hospital admissions. Immobility, surgery, and advanced age increase the risk of blood clot formation. Despite the use of preventative measures, the prevalence of fatal blood clots in the hip fracture population remains high. As such, it is essential to identify those hip fracture patients for whom the benefits of using blood thinners outweigh the potential risks. Thrombelastography (TEG) is a blood test that quantifies a patient's ability to make and dissolve clots and may be used as a novel tool in identifying patients with excessive clotting. TEG measurements provide a wealth of real-time data yet to be fully utilized, especially in the assessment of increased clotting risk.Research QuestionCan TEG analysis be used to identify patients with hip fractures at increased risk for blood clots?Hypotheses: 1) Patients with hip fractures will have increased clotting based on elevated TEG values compared with normal reference values. 2) Some patients will have persistently elevated TEG values 6-weeks after injury.MethodsThe proposed study is a single-centre prospective cohort of hip fracture patients requiring surgical treatment. Patients will undergo serial TEG measurements every 24-hours from hospital arrival until 5-days after surgery. Additionally, follow-up TEG measurements will take place at 2-weeks, 6-weeks and 3-months.Expected OutcomesIt is anticipated that patients with hip fractures will be hypercoagulable and at increased risk of developing blood clots as determined by TEG. As health care becomes increasingly patient-centered, our goal is to use TEG as a point-of-care tool to risk-stratify and provide patient-directed blood clot prevention.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
You, Daniel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~